Open access peer-reviewed chapter

I-131 Metaiodobenzylguanidine Therapy of Neuroectodermal Tumors

By Mine Araz and Derya Çayır

Submitted: September 29th 2016Reviewed: March 15th 2017Published: July 12th 2017

DOI: 10.5772/intechopen.68573

Downloaded: 341

© 2017 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Mine Araz and Derya Çayır (July 12th 2017). I-131 Metaiodobenzylguanidine Therapy of Neuroectodermal Tumors, Radionuclide Treatments Cigdem Soydal, IntechOpen, DOI: 10.5772/intechopen.68573. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/radionuclide-treatments/i-131-metaiodobenzylguanidine-therapy-of-neuroectodermal-tumors" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

341total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Radionuclide Pain Palliation Treatment and Radiosynovectomy

By Elgin Özkan

Related Book

First chapter

Introduction to Infrared Spectroscopy in Life and Biomedical Sciences

By Theophile Theophanides

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us